Ursprung des Netzwerks ersten Grades von Pamela Keck

EinheitArt der EinheitIndustrie
Public Company Biotechnology 9

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Pamela Keck

UnternehmenSektorVerknüpfte PersonenHauptposition
Ludwig-Maximilians-Universität München College/University

Antoinette Hiebeler-Hasner

Dolores Schendel

Undergraduate Degree

Corporate Officer/Principal

BASILEA PHARMACEUTICA AG Pharmaceuticals: Major

Anthony Man

Ronald Scott

President

Chief Executive Officer

Aerospace & Defense

Antoinette Hiebeler-Hasner

Founder

College/University

Ronald Scott

Graduate Degree

Medical Specialties

René Goedkoop

Chief Tech/Sci/R&D Officer

University of Amsterdam College/University

René Goedkoop

Doctorate Degree

Biotechnology

René Goedkoop

Chief Tech/Sci/R&D Officer

Serono International SA

René Goedkoop

Chief Tech/Sci/R&D Officer

ELI LILLY AND COMPANY Pharmaceuticals: Major

René Goedkoop

Corporate Officer/Principal

Medical Specialties

René Goedkoop

Corporate Officer/Principal

PHARNEXT SCA Biotechnology

René Goedkoop

Chief Tech/Sci/R&D Officer

Medical Specialties

René Goedkoop

Chief Tech/Sci/R&D Officer

Investment Managers

Ronald Scott

Director of Finance/CFO

Utah State University College/University

Ronald Scott

Undergraduate Degree

Basilea Pharmaceutical International Ltd.

Ronald Scott

Chief Executive Officer

Pharmaceuticals: Major

Ronald Scott

Director/Board Member

University of Wisconsin College/University

Dolores Schendel

Doctorate Degree

Institute of Molecular Immunology

Dolores Schendel

Director/Board Member

Pharmaceuticals: Major

Dolores Schendel

Chief Executive Officer

Deutsche Forschungsgemeinschaft College/University

Dolores Schendel

Corporate Officer/Principal

German Cancer Aid

Dolores Schendel

Corporate Officer/Principal

Investment Trusts/Mutual Funds

Dolores Schendel

Corporate Officer/Principal

Pharmaceuticals: Major

Dolores Schendel

Chief Executive Officer

CONNECT BIOPHARMA HOLDINGS LIMITED Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

DERMIRA, INC. Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

Imperial College London College/University

Selwyn Ho

Undergraduate Degree

Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

Artemis Catalyst Ltd.

Selwyn Ho

Founder

UCB Pharmaceuticals: Major

Selwyn Ho

Corporate Officer/Principal

NEOVACS Pharmaceuticals: Major

René Goedkoop

Director/Board Member

Medical Distributors

Gerd Zettlmeissl

Chief Executive Officer

Biotechnology

Gerd Zettlmeissl

Chairman

Financial Conglomerates

Frank Mathias

Director/Board Member

Packaged Software

Antoinette Hiebeler-Hasner

Chairman

Other Consumer Services

Antoinette Hiebeler-Hasner

Corporate Officer/Principal

Miscellaneous Commercial Services

Antoinette Hiebeler-Hasner

Corporate Officer/Principal

Wilder Kaiser GmbH Steuerberatungsgesellschaft

Antoinette Hiebeler-Hasner

Corporate Officer/Principal

Investment Trusts/Mutual Funds

Antoinette Hiebeler-Hasner

Corporate Officer/Principal

Aerospace & Defense

Antoinette Hiebeler-Hasner

Chairman

Biotechnology

Frank Mathias

President

Miscellaneous Commercial Services

Frank Mathias

Director/Board Member

Pharmaceuticals: Major

Frank Mathias

Director/Board Member

Mediatum GmbH

Frank Mathias

Director/Board Member

Pharmaceuticals: Major

Frank Mathias

Director/Board Member

Miscellaneous Commercial Services

Frank Mathias

Chief Executive Officer

Medical/Nursing Services

Frank Mathias

Director/Board Member

Statistik

International

Deutschland 21
Vereinigte Staaten 13
Schweiz 7
Frankreich 4
Vereinigtes Königreich 4

Sektoral

Health Technology 23
Consumer Services 10
Commercial Services 4
Electronic Technology 3
Finance 3

Operativ

Director/Board Member 24
Corporate Officer/Principal 20
Chief Executive Officer 13
Chairman 11
Chief Tech/Sci/R&D Officer 9
  1. Börse
  2. Insiders
  3. Pamela Keck
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT